Senate health panel blocks Trump‑nominated Jim O’Neill from leading the National Science Foundation
Republican Senator Bill Cassidy halted the confirmation of Jim O’Neill as NSF director, citing a failure to defend scientific integrity during his tenure at HHS and the CDC, ending the Trump administration’s pick for the agency.
By LAS News Desk · Published 18 Nov 2026, 06:48 WAT · Updated 19 Nov 2026, 09:46 WAT

Nomination rejected
The Senate Committee on Health, Education, Labor and Pensions voted to reject Jim O’Neill’s nomination to become director of the National Science Foundation (NSF) on Wednesday. Committee chair Bill Cassidy, a Republican from Louisiana, announced that O’Neill would not receive a confirmation hearing, ending his bid for the six‑year term that would have placed him at the head of the independent federal agency.
According to Cassidy, O’Neill failed to adequately defend scientific integrity during his time in high-level positions at the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC). The decision comes amid broader concerns about the Trump administration’s recent nominations to key scientific and health posts.
Background
Jim O’Neill held a series of high‑profile positions under the Trump administration. He held the position of acting CDC director from August 2025 through February 2026, having previously held senior roles at HHS under health secretary Robert F. Kennedy Jr. led the department. Cassidy alleged that while at the CDC, O’Neill did not contest what he called irresponsible decisions and remarks by Secretary Kennedy, and that he participated in the removal of Susan Monarez, an action that cast doubt on his independent judgment.
The NSF, an agency that funds basic research across science and engineering, has faced significant budget cuts and a freeze on grant awards during the Trump era. The administration’s choice of O’Neill was therefore seen as a test of whether the agency would regain a more supportive stance from the White House.
The same Senate panel that rejected O’Neill’s nomination had earlier been expected to vote on Heidi Overton’s nomination to lead the Food and Drug Administration (FDA). Overton, a preventive‑care physician who also served in the Trump White House, was withdrawn by the White House after the panel’s leader, Senator Cassidy, indicated that Republican support for her was insufficient.
Why it matters
The rejection of O’Neill has immediate implications for the NSF’s leadership and its ability to navigate the ongoing budget constraints. With the agency’s director position now vacant, the next nominee will face a Democratic‑controlled Senate, potentially altering the political dynamics of the confirmation process.
Stakeholders in the scientific community, including universities, research institutions, and private‑sector innovators, are closely watching the outcome because the NSF’s funding decisions influence a wide range of research projects. The committee’s criticism of O’Neill’s past conduct underscores heightened scrutiny of nominees’ willingness to defend scientific integrity against political pressure.
The episode also reflects broader tensions between the Trump administration and Republican lawmakers over health‑policy appointments. Cassidy’s public statements about both O’Neill and Overton suggest a willingness among some Senate Republicans to push back against nominees perceived as insufficiently independent or supportive of science.
What happens next
Following the committee’s rejection, the White House will need to identify a new candidate for the NSF directorship. The next nominee is expected to appear before a Senate that now has a Democratic majority, which could lead to a different assessment of the nominee’s qualifications and stance on scientific issues.
In parallel, the withdrawal of Heidi Overton’s FDA nomination leaves the agency without a confirmed commissioner. The administration may nominate another candidate, but the Senate health panel’s expressed reservations indicate that any future nominee will need to secure broader bipartisan support before a vote can proceed.
The developments highlight a period of uncertainty for two of the United States’ most important scientific and health agencies, with the outcomes likely to shape research funding and regulatory oversight in the coming years.
Sources
- White House drops its nomination for FDA commissioner — CBS News
- Trump FDA nominee Heidi Overton struggling to win GOP support — CBS News
- White House pulls nomination of Heidi Overton to lead FDA — The Hill
- White House pulls FDA chief nominee Heidi Overton before hearing — Straits Times World
- STAT+: White House pulls nomination of Heidi Overton to lead FDA — STAT News
- Senate committee rejects Trump nominee to lead National Science Foundation — Guardian Science
- STAT+: Cassidy rejects Trump’s pick to lead NSF, saying he failed to ‘stand up for science’ — STAT News
Spotted an error? · Corrections policy
Related stories

Democrats seize control of U.S. Senate after Trump‑backed candidates lose in key races
In the 2026 midterm elections, voters rejected Donald Trump‑endorsed candidates in South Carolina, North Carolina and Texas, handing the Senate to the Democrats and underscoring limits on the president’s influence.
LAS News Desk · 4 Nov 2026, 21:46 WAT · 3 sources

Mary Peltora wins Alaska Senate seat, giving Democrats a 56‑seat majority
Democrat Mary Peltora defeated incumbent Republican Dan Sullivan in Alaska’s ranked‑choice election, expanding the Senate majority to 56‑44 and completing the Democrats’ nine‑seat gain in the 2026 midterms.
LAS News Desk · 18 Nov 2026, 07:18 WAT · 6 sources

Senator Ovie Omo‑Agege refutes Tinubu endorsement, reaffirms support for Peter Obi after switching parties
Former Deputy Senate President Ovie Omo‑Agege has denied a viral video showing him backing President Bola Tinubu, stating he left the APC in May 2026 and now backs Peter Obi as the NDC’s presidential candidate for 2027.
LAS News Desk · 22 Nov 2026, 07:39 WAT · 2 sources

Senate President Akpabui demands proof from Amaechi over alleged 50% NDDC contractor deductions
Senate President Godswill Akpabui has asked former Rivers governor Rotimi Amaechi to produce documentary evidence of a claim that he imposed a 50% cut on payments to Niger Delta Development Commission contractors, warning that political rhetoric alone does not establish fact.
LAS News Desk · 16 Nov 2026, 07:43 WAT · 2 sources

Democrats hold Congress but tight midterm races in Alaska, Mississippi and Colorado remain undecided
Democrats have secured control of both chambers of the US Congress, but final results for key Senate and House races in Alaska, Mississippi and Colorado are pending as ballots are counted.
LAS News Desk · 18 Nov 2026, 21:47 WAT · 2 sources

Sen. Chris Van Holland Announces Challenge to Chuck Schumer for Senate Majority Leader, Calls for Filibuster Reform
Maryland Democrat Chris Van Hollen said he will run for Senate majority leader, opposing incumbent Chuck Schumer, and urged the Senate to abolish the filibuster, while ruling out a 2028 presidential bid.
LAS News Desk · 13 Nov 2026, 22:42 WAT · 9 sources
More Health news ›
- Virginia reports first measles-associated child death of 2026
- NHS England faces 10,000 patient shortfall in cancer treatment target
- Global Microsoft outage disrupts UK NHS, schools, and police services
- American Cancer Society recommends biennial PSA testing for average‑risk men aged 50‑69
- FDA shelves Trump‑era fast‑track drug review programme